VANGUARD GROUP INC - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 27 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$458,921
-29.8%
573,6510.0%0.00%
Q2 2023$653,962
-24.0%
573,6510.0%0.00%
Q1 2023$860,476
+0.7%
573,6510.0%0.00%
Q4 2022$854,740
-3.9%
573,651
+0.0%
0.00%
Q3 2022$889,000
-41.5%
573,456
-14.4%
0.00%
Q2 2022$1,520,000
-12.9%
669,572
-11.4%
0.00%
Q1 2022$1,746,000
-60.1%
755,950
+0.3%
0.00%
Q4 2021$4,371,000
-44.4%
753,695
+0.9%
0.00%
Q3 2021$7,856,000
+107.6%
746,759
+92.6%
0.00%
Q2 2021$3,784,000
-19.8%
387,753
+19.4%
0.00%
Q1 2021$4,718,000324,6960.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Duquesne Family Office 100,000$580,0000.02%
Virtu Financial LLC 15,980$93,0000.01%
Jump Financial, LLC 11,800$68,0000.00%
Investment Research & Advisory Group, Inc. 1,400$4,0000.00%
Cubist Systematic Strategies, LLC 12,804$74,0000.00%
UBS Group AG 22,402$130,0000.00%
RHUMBLINE ADVISERS 18,894$110,0000.00%
Ellevest, Inc. 18$00.00%
TWO SIGMA INVESTMENTS, LP 28,771$167,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 11,105$64,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders